Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
Jalbert JJ, Hussein M, Mastey V, Sanchez RJ, Wang D, Murdock D, Fariñas L, Bussey J, Duart C, Hirshberg B, Weinreich DM, Wei W.
Jalbert JJ, et al. Among authors: farinas l.
Infect Dis Ther. 2022 Dec;11(6):2125-2139. doi: 10.1007/s40121-022-00691-z. Epub 2022 Oct 1.
Infect Dis Ther. 2022.
PMID: 36181639
Free PMC article.